VANI · Vivani Medical, Inc.
$1.40
+0.06 (+4.48%)
At close · Aug 14
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions and events raise substantial doubt about our ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued. ... Because these plans are not fully within our control and their successful execution cannot be considered certain, management has concluded that its plans do not alleviate the substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$118.14M
Shares
90.20M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
FY2025
Net Income
-$26.61M
-13.3%
FY2025
Gross Margin
36.31%
+7.2pp
FY2019
Operating Margin
-1004.85%
-495pp
FY2019
Diluted EPS
-$0.43
0%
FY2025
Operating Cash Flow
-$24.32M
-17%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $0 | $0 | — | — | — | — | $3.38M | $6.9M | $7.96M | $4M | $8.9M | $3.4M | $1.57M | |
| $2004 | — | — | — | — | — | — | — | — | — | — | $2000 | $9000 | $8000 | |
| — | — | — | — | — | $130K | $500K | $2.15M | $4.89M | $5.12M | $10.08M | $5.29M | $3.56M | $5.63M | |
| — | — | — | — | — | $130K | $500K | $1.23M | $2.01M | $2.85M | -$6.09M | $3.66M | -$160K | -$4.06M | |
| — | — | — | — | — | — | — | 36.31% | 29.1% | 35.75% | -152.28% | 41.09% | -4.71% | -259.68% | |
| $18M | $18.13M | $15.75M | $16.97M | $14.17M | $11M | $4.84M | $13.14M | $10.01M | $7.89M | $5.35M | $3.04M | $5.04M | $3.25M | |
| — | — | — | — | — | — | $701K | $6.1M | $11.34M | $9.57M | $8.99M | $8.94M | $6.85M | $3.3M | |
| $9.23M | $9.43M | $8.93M | $10M | $7.07M | $2.32M | $5.94M | $9.23M | $10.69M | $10.93M | $10.08M | $8.22M | $6.57M | $4.17M | |
| $452K | $424K | $400K | $357K | $381K | $345K | $164K | $397K | $435K | $457K | $432K | $335K | $279K | $316K | |
| — | — | — | — | — | — | $2.23M | $3.36M | $555K | — | — | — | — | — | |
| $27.23M | $27.56M | $24.68M | $26.97M | $21.24M | $13.32M | $15.4M | $35.18M | $37.19M | $31.46M | $27.12M | $23.7M | $21.07M | $13.93M | |
| -$27.23M | -$27.56M | -$24.68M | -$26.97M | -$21.24M | -$13.32M | -$14.9M | -$33.95M | -$35.18M | -$28.61M | -$33.21M | -$20.05M | -$21.23M | -$18M | |
| — | — | — | — | — | — | — | -1004.85% | -509.86% | -359.23% | -830.25% | -225.25% | -624.5% | -1150.03% | |
| -$27.36M | -$27.13M | -$24.28M | -$26.61M | -$20.86M | -$12.98M | -$14.73M | -$33.56M | -$34.75M | -$28.15M | -$32.78M | -$19.71M | -$20.95M | -$17.68M | |
| $1.86M | $947K | $1.19M | $1.31M | — | — | — | — | — | — | — | $27K | $12K | — | |
| — | -$26.61M | -$23.49M | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | $2000 | — | — | — | — | $0 | $0 | — | — | — | — | — | |
| -$26.31M | -$26.61M | -$23.49M | -$25.65M | -$13.89M | -$12.77M | -$14.88M | -$33.59M | -$35.09M | -$28.52M | -$33.18M | -$20.02M | -$35.2M | -$22.97M | |
| — | — | — | — | — | — | — | -994.14% | -508.61% | -358.06% | -829.48% | -224.92% | -1035.32% | -1467.67% | |
| -$26.36M | -$26.63M | -$23.58M | -$25.55M | -$13.85M | -$12.77M | -$14.77M | -$33.58M | -$35.1M | -$28.48M | -$33.21M | -$20.13M | -$35.41M | -$23.05M | |
| USD/shares | — | -$0.43 | -$0.43 | -$0.50 | — | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$0.43 | -$0.43 | -$0.50 | — | — | — | — | — | — | — | — | — | — |
| shares | — | 62.39M | 54.98M | 50.85K | — | 10.94M | 6.86M | 4.9M | 2.77M | 2.26M | 1.65M | 1.48M | 1043.875 | 938.375 |
| shares | — | 62.39M | 54.98M | 50.85K | — | 10.94M | 6.86M | 4.9M | 2.77M | 2.26M | 1.65M | 1.48M | 1043.875 | 938.375 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 3.92×
EV/EBIT
—
Peer median 9.33×
P/E (TTM)
—
Peer median 8.85×
Peer medians compare against the 304 similar-size Biotechnology companies (of 545 listed).
Key facts
CIK
1266806
CUSIP
92854B109
13F (30d)
37 filings
37 filers
Visit website
Investor relations